These compounds may interact with:
cAMP-specific 3',5'-cyclic phosphodiesterase 4A
Potentially involved in: carcinoma; chronic obstructive pulmonary disease; asthma; atopic dermatitis; psoriasis; psoriatic arthritis; impotence; bronchitis; schizophrenia; acrodysostosis; hypereosinophilic syndrome; autistic disorder; bipolar disorder; mental depression; depressive disorder; seasonal affective disorder; adrenocortical carcinoma; adult high grade glioma; astrocytic glioma; atypical teratoid / rhabdoid tumor
Disease data sourced from Pharos.